  The present observational study aimed to compare the efficacy of azacitidine ( AZA) and intensive chemotherapy ( IC) in elderly patients with untreated acute myeloid leukemia<disease> ( AML) , diagnosed according to WHO criteria. In the two groups , we evaluated complete remission ( CR) , overall survival ( OS) , and disease-free survival ( DFS). The AZA group included 89 patients; median age was 73 years ( range 61-80) and median white blood cell count ( WBCc) 2.5 Ã— 10